155 related articles for article (PubMed ID: 28294688)
1. Successful Treatment of Classical Hodgkin Lymphoma During Pregnancy in Malawi.
Kasonkanji E; Kaimila B; Amuquandoh A; Chikasema M; Tewete B; van der Gronde T; Gopal S
J Oncol Pract; 2017 May; 13(5):338-340. PubMed ID: 28294688
[No Abstract] [Full Text] [Related]
2. Hodgkin and non-Hodgkin lymphomas during pregnancy.
Froesch P; Belisario-Filho V; Zucca E
Recent Results Cancer Res; 2008; 178():111-21. PubMed ID: 18080448
[No Abstract] [Full Text] [Related]
3. I. Hodgkin lymphoma: special challenges and solutions.
Connors JM
Hematol Oncol; 2015 Jun; 33 Suppl 1():21-4. PubMed ID: 26062048
[No Abstract] [Full Text] [Related]
4. Bulky mediastinal classical Hodgkin lymphoma in young women.
Percival ME; Hoppe RT; Advani RH
Oncology (Williston Park); 2014 Mar; 28(3):253-6, 258-60, C3. PubMed ID: 24855735
[No Abstract] [Full Text] [Related]
5. Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy.
Pinnix CC; Osborne EM; Chihara D; Lai P; Zhou S; Ramirez MM; Oki Y; Hagemeister FB; Rodriguez AM; Samaniego F; Fowler N; Romaguera JE; Turturro F; Fayad L; Westin JR; Nastoupil L; Neelapu SS; Cheah CY; Dabaja BS; Milgrom SA; Smith GL; Horace P; Milbourne A; Wogan CF; Ballas L; Fanale MA
JAMA Oncol; 2016 Aug; 2(8):1065-9. PubMed ID: 27227654
[TBL] [Abstract][Full Text] [Related]
6. Next Questions - Classical Hodgkin Lymphoma (cHL).
Straus DJ
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20 Suppl 1():S103-S104. PubMed ID: 32862849
[No Abstract] [Full Text] [Related]
7. XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
Advani RH; Hoppe RT
Hematol Oncol; 2015 Jun; 33 Suppl 1():90-5. PubMed ID: 26062064
[No Abstract] [Full Text] [Related]
8. [Secondary mediastinal diffuse large B cell lymphoma after the treatment of nodular sclerosis classical Hodgkin lymphoma: a case report].
Han TT; Fan L; Wang L; Xu J; Xu W; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):732. PubMed ID: 23978032
[No Abstract] [Full Text] [Related]
9. XVII. Treatment of advanced-stage Hodgkin lymphoma.
Engert A
Hematol Oncol; 2015 Jun; 33 Suppl 1():87-9. PubMed ID: 26062063
[No Abstract] [Full Text] [Related]
10. [Therapeutic approach against malignant Hodgkin's lymphoma during pregnancy: about a case and literature review].
Alami Z; Bouhafa T; Elmazghi A; Hassouni K
Pan Afr Med J; 2018; 30():20. PubMed ID: 30167048
[TBL] [Abstract][Full Text] [Related]
11. An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma.
Wight JC; Hawkes EA; Berlangieri SU; Khor R; Grigg AP
Leuk Lymphoma; 2018 Nov; 59(11):2749-2751. PubMed ID: 29569979
[No Abstract] [Full Text] [Related]
12. Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016.
Fosså A; Smeland K; Fagerli UM; Galleberg RB; Bersvendsen HS; Holte H
Acta Oncol; 2020 Jan; 59(1):101-105. PubMed ID: 31429371
[No Abstract] [Full Text] [Related]
13. Pre-autologous transplantation PET/CT using Deauville criteria is an independent predictor of progression in relapsed refractory classical Hodgkin lymphoma.
Damlaj M; Ghazi S; Syed G; Pasha T; Gmati G; Salama H; Ali O; Abuelgasim KA; Al-Zahrani M; Hejazi A; Al Askar A
Bone Marrow Transplant; 2017 Sep; 52(9):1342-1344. PubMed ID: 28692029
[No Abstract] [Full Text] [Related]
14. Nivolumab for the treatment of relapsed and refractory classical Hodgkin lymphoma after ASCT and in ASCT-naïve patients.
Lepik KV; Mikhailova NB; Moiseev IS; Kondakova EV; Tsvetkova LA; Zalyalov YR; Borzenkova ES; Babenko EV; Baykov VV; Markova IV; Afanasyev BV
Leuk Lymphoma; 2019 Sep; 60(9):2316-2319. PubMed ID: 30712423
[No Abstract] [Full Text] [Related]
15. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study.
Westmoreland KD; Stanley CC; Montgomery ND; Kaimila B; Kasonkanji E; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kampani C; Dhungel BM; Sanders MK; Krysiak R; Tomoka T; Liomba NG; Dittmer DP; Fedoriw Y; Gopal S
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27781380
[TBL] [Abstract][Full Text] [Related]
16. Successful salvage of primary progressive Hodgkin lymphoma with the combination of post-transplant brentuximab vedotin and radiotherapy: Combining novelty and tradition.
Belia M; Chatzidimitriou C; Rondogianni P; Petsa P; Efstathopoulou M; Konstantinou E; Arapaki M; Asimakopoulos J; Plata E; Konstantopoulos K; Angelopoulou MK; Vassilakopoulos TP
Hematol Oncol; 2021 Apr; 39(2):258-262. PubMed ID: 32905619
[No Abstract] [Full Text] [Related]
17. Outcome at the end of treatment of patients with common and curable childhood cancer types in Blantyre, Malawi.
Chakumatha E; Weijers J; Banda K; Bailey S; Molyneux E; Chagaluka G; Israels T
Pediatr Blood Cancer; 2020 Jul; 67(7):e28322. PubMed ID: 32391955
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin disease/lymphoma.
Hoppe RT; Advani RH; Ambinder RF; Bierman PJ; Bloomfield CD; Blum K; Dabaja B; Djulbegovic B; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hudson MM; Kaminski MS; Love G; Maloney DG; Mansur D; Mauch PM; Moore JO; Schilder RJ; Weiss LM; Winter JN; Yahalom J; Zelenetz AD;
J Natl Compr Canc Netw; 2008 Jul; 6(6):594-622. PubMed ID: 18597713
[No Abstract] [Full Text] [Related]
19. Soluble PD-1 and PD-L1 as potential biomarkers for classical Hodgkin lymphoma.
da Silva PB; Real JM; Ferreira LRP; Esteves GH; Brito FDN; Baiocchi OCG
Hematol Oncol; 2018 Oct; 36(4):709-712. PubMed ID: 30146693
[No Abstract] [Full Text] [Related]
20. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
Karube K; Niino D; Kimura Y; Ohshima K
Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
